His lab is engaged on refining the alanine-scanning assay to some important residues that could properly distinguish between fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological prognosis, And perhaps for blood screening of tauopathies.Quite a few colleagues have created the coun